1. Randomized placebo-controlle6d trial of ritonavir in advanced HIV-1 disease;Cameron;Lancet,1998
2. National Institutes of Health. Cholesterol lowering in the patient with coronary artery disease: physician monograph-national cholesterol education program. September 1997 (NIH Publication 97-3794)
3. Mann M, Piazza-Hepp T, Koller E, Gibert C Abnormal fat distribution in AIDS patients following protease inhibitor therapy. FDA summary. In: Programs and Abstracts of the 5th National Conference on Retroviruses and Opportunistic Infections; Chicago, Illinois, Feb 1–5, 1998 (abstr 412)
4. Visceral abdominal-fat associated with use of indinavir;Miller;Lancet,1998
5. Carr A, Samaras K, Burton S, Freund, J, Chisholm DJ, Cooper DA. A syndrome of peripheral lipodystrophy and insulin resistance due to HIV protease inhibitors. In: Programs and Abstracts of the 5th National Conference on Retroviruses and Opportunistic Infections; Chicago, Illinois: Feb 1–5, 1998 (abstr 410)